Mitsubishi Logistics Obtains CEIV Pharma Certification at Narita International Airport

Dec. 06, 2022

Mitsubishi Logistics Corporation (TOKYO: 9301; Mitsubishi Logistics) announced today that it has obtained the International Air Transport Association (IATA)'s CEIV Pharma certification of its operations at Narita International Airport on November 30, 2022.

CEIV Pharma is a quality certification system for pharmaceutical product transport that was established by the IATA. It is fully compliant with the GDP guidelines (quality management standards for pharmaceutical product transport) of the EU and the World Health Organization. Mitsubishi Logistics participated in the Narita International Airport Community  operated by Narita International Airport, and worked to improve transport quality, aiming to obtain the certification with the support of the operating organization.
This is the second certification that Mitsubishi Logistics has obtained, following its certification at Kansai International Airport.

Mitsubishi Logistics will continue to provide a wide range of high-quality logistics services, from international transport to storage and delivery and will support the supply chain of pharmaceutical products.